10-K: Centrus Energy Corp. Reports Increased Backlog and Progress in HALEU Production in Annual 10-K Filing

Sentiment:

Annual Report


Centrus Energy Corp.'s 2024 10-K filing highlights a strengthened backlog and advancements in High Assay Low-Enriched Uranium (HALEU) production, amidst geopolitical and regulatory challenges.

Delay expectedCentrus was unable to achieve delivery of the 900 kilograms of HALEU UF 6 for Phase 2 by November 2024 due to 5B Cylinder supply issues.The HALEU Operation Contract Phase 2 period of performance, which was to expire on November 6, 2024, was extended to June 30, 2025.
Worse than expectedThe company's gross profit decreased by $0.6 million (or 1%) from 2023 to 2024.The company's net income decreased by $11.2 million (or 13%) from 2023 to 2024.

Summary

  • Centrus Energy Corp.'s 10-K filing for the year ended December 31, 2024, reveals a $3.7 billion backlog, extending to 2040.
  • The company operates in two segments: Low-Enriched Uranium (LEU) and Technical Solutions.
  • The LEU segment supplies nuclear fuel components, while the Technical Solutions segment focuses on advanced uranium enrichment and technical services.
  • Centrus has been awarded multiple Indefinite Delivery, Indefinite Quantity (IDIQ) contracts by the DOE for HALEU deconversion, HALEU production, and LEU production, with a total potential value of $3.4 billion.
  • The company is investing $60 million to expand centrifuge manufacturing in Oak Ridge, Tennessee, and is exploring LEU enrichment alongside HALEU production.
  • Centrus has received a $62.4 million tax credit allocation under the Qualifying Advanced Energy Project Credit (48C) program.
  • The filing addresses risks related to the war in Ukraine, including the Import Ban Act and the Russian Decree, which impact LEU supply from Russia.
  • The company is pursuing waivers from the DOE to continue importing Russian LEU.
  • Centrus faces competition from major LEU producers, many of which are government-owned.
  • The company's long-term liabilities include 2.25% Convertible Notes maturing in 2030 and 8.25% Notes maturing in February 2027.
  • An Executive Order issued on January 20, 2025, has paused the distribution of federal funding, including funding appropriated under the IRA, pending a review of programs for issuing grants, loans, contracts, or any other financial disbursements.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While there are positive developments such as increased backlog and progress in HALEU production, there are also significant risks and challenges related to geopolitical factors, regulatory uncertainty, and financial obligations.

Positives

  • Increased backlog provides revenue visibility.
  • HALEU production facility is operational and has made initial deliveries.
  • IDIQ contracts with DOE provide opportunities for future growth.
  • Investment in manufacturing capacity positions the company for expansion.
  • Tax credit allocation reduces capital expenditure requirements.
  • The company has a diverse base of firm and prospective supply that includes existing inventory of LEU, long-term contracts with enrichment producers, purchases and loans from secondary sources, and spot purchases of SWU, uranium, and LEU.

Negatives

  • The Import Ban Act and Russian Decree create uncertainty around LEU supply from Russia.
  • Competition from government-owned LEU producers.
  • Significant long-term liabilities.
  • Dependence on a small number of large customers.
  • Executive Order 14154, issued on January 20, 2025, has paused the distribution of federal funding, including funding appropriated under the IRA, pending a review of programs for issuing grants, loans, contracts, or any other financial disbursements.

Risks

  • Geopolitical risks, including the war in Ukraine and related sanctions.
  • Regulatory risks, including changes in government policies and priorities.
  • Operational risks, including disruptions to the supply chain and reliance on key suppliers.
  • Financial risks, including long-term liabilities and fluctuating operating results.
  • Legal and compliance risks, including potential liabilities related to the use of hazardous materials.
  • Cybersecurity risks and the potential for security breaches.
  • The potential for the DOE to seek to terminate or exercise its remedies under the 2002 DOE-USEC Agreement and our other agreements with the DOE, or to require modifications to such agreements that are adverse to our interests, may have adverse consequences on the Company.

Future Outlook

Centrus is exploring the opportunity to deploy LEU enrichment alongside HALEU enrichment to meet a range of commercial and U.S. government requirements, which would bring cost synergies while increasing revenue opportunities.

Management Comments

  • The filing does not contain direct quotes from management, but it implies a strategic focus on expanding uranium enrichment capacity and meeting U.S. national security and energy security requirements.

Industry Context

The announcement reflects the increasing importance of nuclear energy for carbon-free power and the growing demand for HALEU to fuel advanced reactors, while also highlighting the challenges posed by geopolitical tensions and supply chain disruptions.

Comparison to Industry Standards

  • The report mentions key competitors like Rosatom/TENEX, Urenco, CNEIC, and Orano, all of which are either wholly or partially government-owned.
  • Centrus's global market share of enrichment for the LEU market is less than 5%.
  • The report cites World Nuclear Association (WNA) data on the production capacity of major LEU suppliers, providing a benchmark for Centrus's position in the industry.
  • The report references the International Atomic Energy Agency (IAEA) report on global inventories of secondary uranium supplies, indicating the importance of strategic physical stockpiles.

Legal Proceedings

  • Centrus and Enrichment Corp. have been named as defendants in lawsuits alleging damages resulting from releases at the facilities we leased in the past at the Portsmouth GDP, and the centrifuge facilities we still lease near Piketon.
  • These claims include allegations of damages that the plaintiffs assert are not covered by the Price-Anderson Act, which claims we and the other defendants have challenged.

Stakeholder Impact

  • The company's performance impacts shareholders through stock value and potential dividends.
  • Employees are affected by the company's ability to attract and retain key personnel and provide job security.
  • Customers rely on the company's ability to provide a reliable supply of nuclear fuel components.
  • Suppliers are impacted by the company's ability to meet its purchase obligations.
  • Creditors are affected by the company's ability to service its debt.

Next Steps

  • The company intends to respond to the NNSA's Request for Information (RFI) for industry input on an AC100 deployment demonstration.
  • The company will continue to evaluate both positive and negative evidence that would require changes to the remaining federal and state valuation allowances.
  • The company will continue to monitor the situation closely and assess the potential impact of any new sanctions and how the impact on the Company might be mitigated.

Key Dates

DateDescription
June 17, 2002Date of the 2002 DOE-USEC Agreement.
March 23, 2011Date of the Enriched Product Transitional Supply Contract between USEC and TENEX.
September 30, 2014Date of Centrus's reorganization and application of fresh start accounting.
April 6, 2016Date of the Section 382 Rights Agreement.
April 27, 2018Date of the Purchase and Sale Agreement between Orano Cycle and United States Enrichment Corporation.
October 31, 2019Date of the HALEU Demonstration Contract with the DOE.
October 2020DOC reached an agreement with the Russian Federation on an extension of the RSA.
February 2, 2021Date of the Exchange Agreement with Kulayba LLC.
November 10, 2022Date the Company was awarded the HALEU Operation Contract.
November 30, 2022Date of Amendment 3 to Appendix 1 Lease Agreement between the U.S. Department of Energy and United States Enrichment Corporation for the Gas Centrifuge Enrichment Plant.
December 29, 2022Date Centrus amended and restated the Warrant and entered into a Voting Rights Agreement with the MB Group.
October 12, 2023Date the Company entered into an agreement with an insurer for one of its defined benefit plans to purchase a group annuity contract.
November 7, 2023The Company announced that it made its first delivery of HALEU to the DOE, completing Phase 1 by successfully demonstrating its HALEU production process.
May 13, 2024The Import Ban Act was enacted.
May 28, 2024The Company entered into an agreement with a second insurer for two of its defined benefit plans to purchase a group annuity contract.
November 7, 2024The Company issued $402.5 million aggregate principal amount of 2.25% Convertible Notes.
November 14, 2024The government of the Russian Federation passed the Russian Decree.
December 20, 2024The DOEs National Nuclear Security Administration (NNSA) announced that it had released a Request for Information (RFI) for industry input on an AC100 deployment demonstration.
January 20, 2025Executive Order 14154 was issued.
February 4, 2025We signed an agreement with Korea Hydro & Nuclear Power (KHNP) definitizing $0.8 billion of the $1.2 billion of contingent commitments, that were subject to contract definitization, as of December 31, 2024.

Keywords

HALEU, LEU, Uranium Enrichment, Backlog, DOE, TENEX, Nuclear Fuel, Centrus Energy, SWU, Production Contract

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.